Keywords: Daiichi Sankyo, Terumo, Vaccine development, Infectious diseases

Daiichi Sankyo and Terumo link up for vaccine development

Article | 27 February 2012

Print This

Drug major Daiichi Sankyo (TYO: 4568) and fellow Japanese company Terumo Corp (TYO: 4543) have entered into an agreement to co-develop a ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in